NeuroPulse Logo
NeuroPulse - Caring before Curing

Real-time Parkinson's Care

Personalized. Intelligent.

Deep tech that combines wearables, video assessments and patient input to help professionals deliver truly personalized care.

Parkinson's patients are left waiting while symptoms get worse

4+ Months Wait

Average time for a patient to see a neurologist to adapt their treatment plan.

Specialists Overloaded

Manual tasks and fragmented data limit response time and reduce assessment quality.

No Real-Time Visibility

Symptoms change daily. Care decisions happen months apart.

Avoidable Hospitalizations

One in four patients is admitted each year, with significant health and economic consequences.

By 2050, Parkinson's will be the most prevalent neurodegenerative disease

Spain is expected to diagnose 500,000 cases by 2050, increasing annual healthcare costs by 2500M€.

Real-time, personalized Parkinson's care powered by AI

Continuous Monitoring

Wearables, video assessments, and AI voice agents track motor and non-motor symptoms daily.

Tailored Treatment Suggestions

AI analyzes patterns to propose dose and schedule changes. Clinicians approve or adjust in seconds.

Early Risk Alerts

Flags patterns linked to deterioration or hospital risk. Enables proactive intervention before escalation.

Efficient Triage

Highlights complex cases. Reduces time spent on stable patients without missing key changes.

Patient-First Tools

Simple interface with medication reminders, guided video check-ins, and real-time voice support.

Scalable Care

One specialist can oversee hundreds of patients with high-frequency input and structured insights.

A digital care platform that adapts to each patient's unique needs in real-time.

Founding Team

Manuel Rico

Manuel Rico, MD

Chief Executive Officer

Medical Graduate

Oxford & USC.gal

Prev @ Harvard & Charité

Santiago Rodrigo

Santiago Rodrigo

Chief Strategy Officer

Software Engineer

MIT & UPM

Prev @ Amazon & Fluviq

Carlos G. Meixide

Carlos G. Meixide

Chief Technical Officer

PhD Causal Inference

Berkeley & CSIC

Prev @ Roche

Eva Salas

Eva Salas

Chief Sales Officer

Medical Devices PM. MBA

Medtronic

Prev @ Bayer & Sanofi

Collaborators & Advisors

Diego Santos
A Coruña Hospital

Diego Santos, MD

Neurologist

Head of the Movement Disorders Unit at the Hospital of A Coruña & President of the DEGEN Foundation.

Pilar Sanchez
Puerta de Hierro Hospital

Pilar Sanchez, MD

Neurologist

Head of the Movement Disorders Unit at Puerta de Hierro Hospital in Madrid.

VisionMD
Degen Foundation

Strategic Partners

Research & Development

Collaborating in AI development and clinical validation.

Let's transform neurological care together

If you want to join a pilot, collaborate or invest—